Garcia v. Secretary of Health and Human Services
Garcia
Court
United States Court of Federal Claims
Decided
June 27, 2025
Jurisdiction
FS
Importance
45%
Case Summary
In the United States Court of Federal Claims ) CRISTIAN GARCIA, ) ) Petitioner, ) ) No. 21-1601V v. ) (Filed Under Seal: June 12, 2025 ) Reissued for Publication: SECRETARY OF HEALTH AND HUMAN ) June 27, 2025) * SERVICES, ) ) Respondent. ) ) ) Ronald C. Homer, Conway, Homer, P.C., Boston, MA, for Petitioner. Felicia D. Langel, Trial Attorney, Torts Branch, Civil Division, U.S. Department of Justice, Washington, DC, with whom were Julia M. Collison, Assistant Director, Heather L. Pearlman, Deputy Director, C. Salvatore D’Alessio, Director, and Yaakov M. Roth, Acting Assistant Attorney General, for Respondent. OPINION AND ORDER This case arises under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-1 to -34 (“Vaccine Act” or “the Act”). Petitioner, Cristian Garcia, alleges that he developed anti-N-methyl-D-aspartate receptor (“anti-NMDAR” or “anti-NMDA receptor”) encephalitis as a result of receiving the tetanus-diphtheria-acellular-pertussis (“Tdap”) vaccine. See Decision of Spec. Mstr., ECF No. 64 [hereinafter “Dec.”]; see also Garcia v. Sec’y of Health & Hum. Servs., 2025 WL 1544677, 2025 U.S. Claims LEXIS 1412 (Fed. Cl. Spec. Mstr. Jan. 3, 2025). Chief Special Master Brian Corcoran denied entitlement on the grounds that Mr. Garcia failed to satisfy prongs one and two of the three-pronged test of causation set forth in Althen v. Sec’y of Health & Hum. Servs., 418 F.3d 1274 (Fed. Cir. 2005). The Chief Special Master held that: 1) Petitioner did not provide a medical theory based on a “sound and reliable medical or scientific explanation” supporting his assertion that the Tdap vaccine can cause anti-NMDAR encephalitis (prong one), see Pafford v. Sec’y of Health & Hum. Servs., 451 F.3d 1352, 1355–56 (Fed. Cir. 2006); and 2) Petitioner did not provide a logical sequence of cause and effect showing that the vaccination did cause his injury (prong two). * Pursuant to Vaccine Rule 18(b), this opinion was initially filed on June 12, 2025, and the parties were afforded fourteen days to propose redactions. The parties did not propose any redactions and, accordingly, this Opinion is reissued in its original form for publication. The case is currently before the Court on Petitioner’s motion for review. Pet’r’s Mot. for Rev., ECF No. 65. In his motion, Petitioner alleges that the Chief Special Master’s findings were not based on the record as a whole, as required by statute, because the Chief Special Master allegedly failed to take into consideration two reports that the Petitioner’s expert prepared in response to the reports of the Secretary’s experts. For the reasons set forth below, the Court finds that Petitioner has not established that the Chief Special Master failed to consider the two reports at issue and that, even if he did, such error was harmless. Petitioner’s motion for review is therefore DENIED. BACKGROUND I. Mr. Garcia Is Diagnosed with Anti-NMDAR Encephalitis The factual background of this case is set forth in the Chief Special Master’s decision. Dec. at 2–5. To summarize, Mr. Garcia received the Tdap vaccine on October 2, 2020. Pet’r’s Ex. 1, at 4, ECF No. 13-1. He was then twenty-six years old, had no history of neurological problems, and had never before experienced any adverse reaction to a vaccine. See Pet’r’s Ex. 7, at 7–14, ECF No. 13-7. On October 20, 2020, eighteen days after he received the vaccine, Mr. Garcia had a seizure while driving, marking the onset of his disease. See Pet’r’s Ex. 4, at 31–33, ECF No. 13- 4; Pet’r’s Ex. 3, at 5–6, ECF No. 13-5; Pet’r’s Ex. 7, at 16, 21. After experiencing worsening symptoms and undergoing a series of tests, see, e.g., Pet’r’s Ex. 4, at 11, 16, 18; Pet’r’s Ex. 3, at 8; Pet’r’s Ex. 6, at 22, 27, 31–34, 37–39, 44–45, ECF No. 13-6; Pet’r’s Ex. 15, at 64–67, ECF No. 21-3; Pet’r’s Ex. 5, at 2, 70, ECF No. 13-5, Mr. Garcia was diagnosed with anti-NMDAR encephalitis, Pet’r’s Ex. 8, at 135, 162, ECF No. 13-8. Anti-NMDAR encephalitis is an autoimmune, neuroinflammatory disease. Its exact etiology is in many cases unknown. It results when specific antibodies, known as NMDA receptor antibodies, bind to a certain subunit of NMDA receptors found in the central nervous system and block their proper functioning. De
Case Details
Case Details
Legal case information
Status
Decided
Date Decided
June 27, 2025
Jurisdiction
FS
Court Type
federal
Legal Significance
Case importance metrics
Metadata
Additional information
Quick Actions
Case management tools
Case Summary
Summary of the key points and legal principles
In the United States Court of Federal Claims ) CRISTIAN GARCIA, ) ) Petitioner, ) ) No. 21-1601V v. ) (Filed Under Seal: June 12, 2025 ) Reissued for Publication: SECRETARY OF HEALTH AND HUMAN ) June 27, 2025) * SERVICES, ) ) Respondent. ) ) )
Ronald C. Homer, Conway, Homer, P.C., Boston, MA, for Petitioner.
Felicia D. Langel, Trial Attorney, Torts Branch, Civil Division, U.S. Department of Justice, Washington, DC, with whom were Julia M. Collison, Assistant Director, Heather L. Pearlman, Deputy Director, C. Salvatore D’Alessio, Director, and Yaakov M. Roth, Acting Assistant Attorney General, for Respondent.
OPINION AND ORDER
This case arises under the National Childhood Vaccine Injury Act of 1986, 42 U.S.C.
§§ 300aa-1 to -34 (“Vaccine Act” or “the Act”). Petitioner, Cristian Garcia, alleges that he developed anti-N-methyl-D-aspartate receptor (“anti-NMDAR” or “anti-NMDA receptor”) encephalitis as a result of receiving the tetanus-diphtheria-acellular-pertussis (“Tdap”) vaccine. See Decision of Spec. Mstr., ECF No. 64 [hereinafter “Dec.”]; see also Garcia v. Sec’y of Health & Hum. Servs., 2025 WL 1544677, 2025 U.S. Claims LEXIS 1412 (Fed. Cl. Spec. Mstr. Jan. 3, 2025). Chief Special Master Brian Corcoran denied entitlement on the grounds that Mr. Garcia failed to satisfy prongs one and two of the three-pronged test of causation set forth in Althen v. Sec’y of Health & Hum. Servs., 418 F.3d 1274 (Fed. Cir. 2005). The Chief Special Master held that: 1) Petitioner did not provide a medical theory based on a “sound and reliable medical or scientific explanation” supporting his assertion that the Tdap vaccine can cause anti-NMDAR encephalitis (prong one), see Pafford v. Sec’y of Health & Hum. Servs., 451 F.3d 1352, 1355–56 (Fed. Cir. 2006); and 2) Petitioner did not provide a logical sequence of cause and effect showing that the vaccination did cause his injury (prong two).
-
Pursuant to Vaccine Rule 18(b), this opinion was initially filed on June 12, 2025, and the parties were afforded fourteen days to propose redactions. The parties did not propose any redactions and, accordingly, this Opinion is reissued in its original form for publication. The case is currently before the Court on Petitioner’s motion for review. Pet’r’s Mot. for Rev., ECF No. 65. In his motion, Petitioner alleges that the Chief Special Master’s findings were not based on the record as a whole, as required by statute, because the Chief Special Master allegedly failed to take into consideration two reports that the Petitioner’s expert prepared in response to the reports of the Secretary’s experts.
For the reasons set forth below, the Court finds that Petitioner has not established that the
Chief Special Master failed to consider the two reports at issue and that, even if he did, such error was harmless. Petitioner’s motion for review is therefore DENIED.
BACKGROUND
I. Mr. Garcia Is Diagnosed with Anti-NMDAR Encephalitis
The factual background of this case is set forth in the Chief Special Master’s decision.
Dec. at 2–5. To summarize, Mr. Garcia received the Tdap vaccine on October 2, 2020. Pet’r’s Ex. 1, at 4, ECF No. 13-1. He was then twenty-six years old, had no history of neurological problems, and had never before experienced any adverse reaction to a vaccine. See Pet’r’s Ex. 7, at 7–14, ECF No. 13-7.
On October 20, 2020, eighteen days after he received the vaccine, Mr. Garcia had a
seizure while driving, marking the onset of his disease. See Pet’r’s Ex. 4, at 31–33, ECF No. 13- 4; Pet’r’s Ex. 3, at 5–6, ECF No. 13-5; Pet’r’s Ex. 7, at 16, 21. After experiencing worsening symptoms and undergoing a series of tests, see, e.g., Pet’r’s Ex. 4, at 11, 16, 18; Pet’r’s Ex. 3, at 8; Pet’r’s Ex. 6, at 22, 27, 31–34, 37–39, 44–45, ECF No. 13-6; Pet’r’s Ex. 15, at 64–67, ECF No. 21-3; Pet’r’s Ex. 5, at 2, 70, ECF No. 13-5, Mr. Garcia was diagnosed with anti-NMDAR encephalitis, Pet’r’s Ex. 8, at 135, 162, ECF No. 13-8.
Anti-NMDAR encephalitis is an autoimmune, neuroinflammatory disease. Its exact
etiology is in many cases unknown. It results when specific antibodies, known as NMDA receptor antibodies, bind to a certain subunit of NMDA receptors found in the central nervous system and block their proper functioning. De
Case Information
Detailed case metadata and classifications
Court Proceedings
Document Details
Legal Classification
Judicial Panel
Similar Cases
Cases with similar legal principles and precedents
Case Details
Legal case information
Status
Decided
Date Decided
June 27, 2025
Jurisdiction
FS
Court Type
federal
Legal Significance
Case importance metrics
Metadata
Additional information
Quick Actions
Case management tools